Milan, Italy

Claudio Masotto

This inventor holds 1 USPTO granted patent. Top assignee: Zambon Group. Active years: 2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Claudio Masotto. Retrieved from https://idiyas.com/inventor/claudio-masotto

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2000

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Claudio Masotto: Innovator in Dopaminergic Research

Introduction

Claudio Masotto is a notable inventor based in Milan, Italy. He has made significant contributions to the field of pharmacology, particularly in the development of compounds that interact with the dopaminergic system. His work is characterized by a focus on innovative chemical derivatives that have potential therapeutic applications.

Latest Patents

Masotto holds a patent for "Naphthothiazolone derivatives active on the D.sub.3 dopaminergic receptor." This invention highlights his expertise in creating novel compounds that may influence dopamine receptor activity, which is crucial for various neurological functions.

Career Highlights

Claudio Masotto is associated with Zambon Group S.p.a., a company known for its commitment to research and development in the pharmaceutical sector. His role at Zambon has allowed him to explore and expand his innovative ideas in drug development.

Collaborations

Throughout his career, Masotto has collaborated with esteemed colleagues such as Felice Pocchiari and Paolo Cavalleri. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Claudio Masotto's contributions to the field of pharmacology through his innovative patents and collaborations underscore his importance as an inventor. His work continues to pave the way for advancements in therapeutic solutions targeting the dopaminergic system.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…